Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2025
Corrigendum to "Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group": [Ann Oncol 35 (2024) 588-606]
M F Mosele, C B Westphalen, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 2024
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
M F Mosele, C B Westphalen, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 3, 2012
Genomic grade adds prognostic value in invasive lobular carcinoma
O Metzger-Filho, S Michiels, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2020
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F Mosele, J Remon, J Mateo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2016
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers
D Fumagalli, T R Wilson, R Salgado, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
September 25, 2021
[Surgery or not on an atypical breast lesion? Taking anxiety into account in shared decision support from a prospective cohort of 300 patients]
A Favier, D Boinon, F Salviat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 26, 2024
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development
C B Westphalen, D Martins-Branco, J R Beal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2025
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancer
A Mamann, Y Pradat, F C Bidard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
C R Lindsay, F H Blackhall, A Carmel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2019
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis
A R Ferreira, A Di Meglio, B Pistilli, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2025
Corrigendum to "Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group": [Ann Oncol 35 (2024) 588-606]
M F Mosele, C B Westphalen, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 2024
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
M F Mosele, C B Westphalen, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 3, 2012
Genomic grade adds prognostic value in invasive lobular carcinoma
O Metzger-Filho, S Michiels, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2020
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F Mosele, J Remon, J Mateo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2016
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers
D Fumagalli, T R Wilson, R Salgado, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
September 25, 2021
[Surgery or not on an atypical breast lesion? Taking anxiety into account in shared decision support from a prospective cohort of 300 patients]
A Favier, D Boinon, F Salviat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 26, 2024
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development
C B Westphalen, D Martins-Branco, J R Beal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2025
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancer
A Mamann, Y Pradat, F C Bidard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
C R Lindsay, F H Blackhall, A Carmel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2019
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis
A R Ferreira, A Di Meglio, B Pistilli, et al.
Page
of 6